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The ubiquitin-proteasome pathway (UPP) is a hallmark of the eukaryotic cell. In jawed 
vertebrates, it has been co-opted by the adaptive immune system, where proteasomal 
degradation produces endogenous peptides for major histocompatibility complex class 
I antigen presentation. However, proteolytic products are also necessary for the phylo-
genetically widespread innate immune system, as they often play a role as host defense 
peptides (HDPs), pivotal effectors against pathogens. Here, we report the identification 
of the arachnid HDP oligoventin, which shares homology to a core member of the UPP, 
E3 ubiquitin ligases. Oligoventin has broad antimicrobial activity and shows strong syn-
ergy with lysozymes. Using computational and phylogenetic approaches, we show high 
conservation of the oligoventin signature in HECT E3s. In silico simulation of HECT E3s 
self-proteolysis provides evidence that HDPs can be generated by fine-tuned 26S pro-
teasomal degradation, and therefore are consistent with the hypothesis that oligoventin 
is a cryptic peptide released by the proteolytic processing of an Nedd4 E3 precursor 
protein. Finally, we compare the production of HDPs and endogenous antigens from 
orthologous HECT E3s by proteasomal degradation as a means of analyzing the UPP 
coupling to metazoan immunity. Our results highlight the functional plasticity of the UPP 
in innate and adaptive immune systems as a possibly recurrent mechanism to generate 
functionally diverse peptides.
Keywords: hecT ligases, host defense, immune evolution, innate immunity, nedd4, synergy, ubiquitination, 
ubiquitin–proteasome system
inTrODUcTiOn
The ubiquitin-proteasome pathway (UPP) is central to the eukaryotic cell, being involved virtu-
ally in every intracellular pathway, including protein posttranslational modifications, fine-tuned 
proteolysis, autophagy, cell cycle regulation, programed cell death, cell signaling, transcriptional 
regulation, gene expression, protein and mRNA turn over, cancer development, viral budding, and 
immune evasion by pathogens (1–10). Precise posttranslational modifications of proteins by ubiq-
uitin or ubiquitin-like proteins involve the multistep, hierarchical transfer of ubiquitin to a substrate 
by ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin-protein 
ligases (E3) (1–10). Repeating this process generates polyubiquitin chains, which function as a 
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signal for degradation via the 26S proteasome (1–10). In addi-
tion to the temporal, spatial, and context-specific regulation of 
the UPP, the large number of UPP targets is tightly regulated 
by the specificity-conferring components, E3s (3–7). As part of 
jawed vertebrates’ immune systems, E3s specify host defense 
signal transduction pathways, transcriptional regulation, and 
targeted proteolysis of cytosolic proteins for production of 
endogenous antigens, which are then presented to cytotoxic 
T cells mediated by major histocompatibility complex (MHC) 
class I receptors (1–10). Remarkably, bacteria have also evolved 
E3 ligases mimicking eukaryotic ones as an adaption to evade 
host defense (10–15).
In contrast to the adaptive immune system, which is restricted 
to jawed vertebrates and is based on humoral and cellular 
responses with specificity for antigens (1–10, 16), the phylo-
genetically widespread and more ancient innate defense relies 
on pattern recognition molecules conferring specificity against 
pathogens, complex signaling pathways leading to phagocytosis, 
encapsulation, and production of effector molecules with broad 
activity against pathogens (3, 4, 16–21). Recently, emerging roles 
in the innate immune system have been attributed to ubiquitin 
(22–29). Ubiquitin degradation produces host defense peptides 
(HDPs) (22–28), pivotal players in the innate defense against 
microbial pathogens (17–19). Additionally, more than 70 immu-
nosuppressive peptides have been discovered originating from 
ubiquitin degradation in vitro (22, 30, 31). However, production 
of antimicrobial and immunomodulatory peptides is a complex, 
multilayered process (17–19, 22, 26, 28, 30, 31): it involves the 
canonical expression of transcriptionally regulated gene-encoded 
peptides (17–19) and fast production of cryptic peptides [that 
is, release of protein fragments with distinct properties from 
that of the original protein (19, 22, 26, 28)]. Therefore, the UPP 
orchestrates biologically active peptide production in both the 
innate and the adaptive metazoan immune systems by generat-
ing the recently discovered ubiquitin-encrypted HDPs (22–28), 
E3-mediated transcriptional regulation of host defense gene 
expression (3, 4, 6, 7, 10), and production of short fragments for 
MHC class I-mediated antigen presentation (3, 4, 8, 9, 16).
However, ubiquitin is highly constrained, with only three 
amino acids varying between yeast and human primary 
sequences (1–7, 22). Such constraint greatly reduces its potential 
to generate diverse HDPs. In contrast, E3s are larger, highly 
diversified, evolutionarily less conserved, and hold high affinity 
toward their molecular targets (1–7), which probably makes 
them a more enriched substrate than ubiquitin for encrypted 
HDPs. Surprisingly, little is known about the physiological roles 
that proteasomal degradation-derived fragments play, except for 
MHC class I antigens (3, 4, 8, 9, 16). Here, we hypothesize that 
similar to ubiquitin, E3 ligases harbor a defensive arsenal that 
can be released by fine-tuned proteolysis and thereby represent a 
novel scaffold for cryptic peptide discovery.
Among organisms that lack the adaptive immune system, 
arachnids’ innate defenses are remarkably enriched for HDPs 
(19–21). Identification of many classes of antimicrobial peptides 
that appeared early in evolution (17–21), such as glycine-rich 
peptides (19, 32, 33), tachyplesin-like HDPs (19, 34), defensins 
(19–21), lysozymes (20), and hemocyanin-derived antifungal 
peptides (19, 35) are consistent with their phylogenetic position 
at the base of extant arthropods’ phylogeny (19, 20, 34–36). Thus, 
investigating the arachnid innate immune peptidome is a promis-
ing approach to identify ancient host defense effectors, including 
cryptic HDPs.
Here, we describe the discovery and characterization of olig-
oventin, an arachnid HDP isolated from the eggs of the Brazilian 
armed spider Phoneutria nigriventer (Ctenidae, Araneomorphae). 
Based on bioinformatics analysis, we suggest that oligoventin is 
a cryptic peptide derived from the proteasomal degradation of 
E3s. Bayesian phylogenetic analysis indicates that oligoventin 
appeared early in evolution and its production is likely not 
restricted to arachnids. Moreover, oligoventin inhibits growth 
of yeast, Gram-positive and Gram-negative bacteria and also 
exhibits synergy with lysozymes against Micrococcus luteus A270, 
consistent with the proposed function as a host defense effector. 
Furthermore, investigating mouse and human immune epitopes 
derived from the proteasomal degradation of E3s uncovered eight 
sequences, which are indeed involved in MHC class I antigen 
presentation. Our results provide, to our knowledge, the first 
evidence that proteasomal-mediated protein degradation evolved 
independently to produce functional short-sized peptides in 
the adaptive immunity of jawed vertebrates and possibly in the 
innate defense of arachnids, thus highlighting a recurrent role 
of the UPP in the generation of functionally diverse peptides in 
metazoan immune systems.
MaTerials anD MeThODs
animals
Adult female P. nigriventer spiders laid eggs in captivity. Eggs were 
separated from silk and stored at −20°C for later use. These ani-
mals were collected under license Permanent Zoological Material 
no. 11024-3-IBAMA and Special Authorization for Access to 
Genetic Patrimony no. 001/2008.
Microorganisms
Fungal and bacterial strains were obtained from various sources. 
Escherichia coli SBS363 and M. luteus A270 were from the 
Pasteur Institute (Paris); Candida albicans (MDM8) was from the 
Department of Microbiology from the University of São Paulo 
(Brazil); E. coli ATCC 25922, Pseudomonas aeruginosa ATCC 
27853, Serratia marcescens ATCC4112, Staphylococcus aureus 
ATCC 29213, and Staphylococcus epidermidis ATCC 12228 
were from the American Type Culture Collection (ATCC). The 
following human clinical yeast isolates, which can be agents of 
candidiasis, obtained from the Oswaldo Cruz Institute (Brazil) 
were also used: Trichosporon sp. IOC 4569, Candida krusei IOC 
4559, Candida glabrata IOC 4565, C. albicans IOC 4558, Candida 
parapsilosis IOC 4564, Candida tropicalis IOC 4560, and Candida 
guilliermondii IOC 4557.
activity-guided isolation of host Defense 
effectors from P. nigriventer eggs
Purification of antimicrobials was carried out following the 
strategies described elsewhere (37, 38). In brief, eggs were 
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suspended in 20 mL of glacial acetic acid and homogenized. The 
insoluble material was removed by centrifugation at 16,000 g for 
30 min. The supernatant was partially purified by applying it in 
two Sep-Pak C18 (Light tC18—Water Associates) cartridges con-
nected in series equilibrated in 0.05% trifluoroacetic acid, and 
protein-concentrated fractions were eluted in three steps using 5, 
40, and 80% of acetonitrile in acidified water. Only the protein-
concentrated fraction eluted in 40% acetonitrile was directly 
used for HPLC purifications. Fractionation was carried out using 
a reversed-phase high-performance liquid chromatography 
(RP-HPLC) semipreparative C18 column (Jupiter, 10 × 250 mm), 
equilibrated in 2% acetonitrile, and 0.05% trifluoroacetic acid. 
Elution was successfully performed with a linear 2–60% gradient 
of solution B [0.10% (v/v) trifluoroacetic acid in acetonitrile] 
in acidified water {solution A [0.05% (v/v) trifluoroacetic acid 
in water]} run for 60 min at a flow rate of 1.5 mL/min. Effluent 
absorbance was monitored at 225  nm. Fractions with antimi-
crobial activity were further purified using an analytical Jupiter 
C18 column (250 mm × 4.6 mm) at a flow rate of 1.0 mL/min in 
60 min with distinct gradients: from 33.5 to 43.5% of acetonitrile 
in acidified water for fraction containing the HDP of 1.4  kDa 
(Figure S1A in Supplementary Material), 22.5 to 32.5% for the 
oligoventin-enriched fraction (Figure 1B), 27.5 to 37.5% for the 
anti-M. luteus lysozyme (Figure S1C in Supplementary Material), 
and 34.5 to 44.5% for the anti-C. albicans lysozyme (Figure S1D 
in Supplementary Material). A symmetrical peak on the HPLC 
system, amino acid sequencing, and mass spectrometry analysis 
ascertained the purity of the peptide or protein. Fractions were 
lyophilized in a SpeedVac Concentrator.
growth inhibition assays
During the purification procedure, antimicrobial activities were 
detected or monitored by liquid growth inhibition assays as 
described in Ref. (38–40), using the Gram-negative bacteria E. 
coli SBS363 and Gram-positive bacteria M. luteus A270 that were 
cultured in poor broth nutrient medium (PB: 1.0 g peptone in 
100 mL of water containing 86 mM NaCl at pH 7.4; 217 mOsM), 
and the yeast strain C. albicans MDM8, cultured in poor dextrose 
broth (1/2 PDB: 1.2 g potato dextrose in 100 mL of H2O at pH 5.0; 
79 mOsM) used at half strength. Determination of antimicrobial 
activity was performed using fivefold micro titer broth dilution 
assay in 96-well sterile plates at a final volume of 100 mL. Mid-
log phase culture was diluted to a final concentration of 1 × 105 
colony forming units/mL. Dried fractions were dissolved in 
200 µL of ultrapure water and 20 µL applied in to each well and 
added to 80 µL of the bacterium/yeast dilution. A total of 100 µL 
of sterile water and PB or PDB were used as quality controls. 
Tetracycline and/or amphotericin B were also used as controls 
for growth inhibition. The microtiter plates were incubated for 
18  h at 30°C; growth inhibition was determined by measuring 
absorbance at 595 nm.
Minimal inhibitory concentrations (MICs) were determined 
using the purified peptide against Gram-negative, Gram-positive, 
fungal, and yeast strains. MIC determination was performed 
using a fivefold microtiter broth dilution assay of stock solution, 
and serial dilution in 96-well sterile plates at a final volume of 
100 µL where 20 µL of stock solution was applied in to each well 
at serial dilution twofold microtiter broth dilution and added to 
80 µL of the bacterium/yeast dilution. MIC is defined as the mini-
mal concentration of peptide that caused 100% growth inhibition 
(33–35, 38, 39). In an attempt to test how rich broth medium 
affects oligoventin activity, growth inhibition assays were carried 
out using RPMI-1640 (Sigma-Aldrich) with MOPS 0.165 mol/L 
(RPMI without bicarbonate 10.4 g/L; MOPS [3-(n-morpholino)
propanesulfonic acid] 34.53  g/L) at pHs 7.0 and 5.0 against 
C. albicans MDM8.
Synergy was measured by checkerboard titration assays 
using a fivefold microtiter broth dilution assay of stock solution 
and serial dilution in 96-well sterile plates at a final volume of 
100 µL. Oligoventin was diluted along the rows of a microtiter 
tray and the avian lysozyme was diluted along the columns. A 
total of 80  µL of M. luteus was added to each well, diluted to 
a final concentration of 1 ×  105 colony forming units/mL. The 
fractional inhibitory concentration (FIC) was determined after 
18 h of incubation of the plates at 30°C. Synergy was defined as an 
FIC index of 0.5 or less as it represents at least fourfold decrease 
in the MIC of each compound (41), calculated according to the 
following formula: FIC index =  [A]/MICA +  [B]/MICB, where 
[A] was the concentration of drug A in a well that represented 
the lowest inhibitory concentration in its row, MICA was the MIC 
of drug A alone, [B] was the concentration of drug B in a well 
that represented the lowest inhibitory concentration in its row, 
and MICB was the MIC of drug B alone. Growth inhibition was 
determined by measuring absorbance at 595 nm. Bioassays were 
done in triplicate.
Oligoventin Toxicity to erythrocytes
The hemolytic activity of oligoventin was tested in duplicate using 
human erythrocytes. A 2.5% (v/v) suspension of erythrocytes 
washed in PBS was incubated with oligoventin ranging from 0.4 
to 188.8 µM in a 96-well plate for 3 h with intermittent shaking. 
The absorbance in the supernatant was measured at 415  nm. 
Hemolysis caused by PBS and 1% (v/v) Triton X-100 were used 
as 0 and 100% controls, respectively.
Molecular Mass characterization and 
sequence Determination
The fractions enriched for peptides were spotted (0.5 µL) onto 
the sample slide, dried on the bench, and crystallized with 
0.5  µL of matrix solution [5  mg/mL (w/v) CHCA (α-cyano-4-
hydroxycinnamic acid), in 50% acetonitrile and 0.1% TFA] 
(Sigma). The samples were analyzed on an Ettan MALDI-ToF/Pro 
spectrometer (Amersham Biosciences) operating in reflectron 
and positive ion mode. To determine the amino acid sequence 
of peptides, Edman degradation was performed in a PPSq 21 
Automated Protein Sequencer (Shimadzu Co., Japan). Lysozymes 
were analyzed by SDS polyacrylamide gel electrophoresis (12.5% 
SDS-PAGE). In-gel lysozymes were destained, dehydrated in 
100% acetronitrile for 10 min, and lyophilized. Freeze-dried puri-
fied protein was dissolved (1 mg/mL) in denaturant buffer [6 M 
GdmCl (guanidinium chloride), 0.25  M Tris/HCl, and 1  mM 
EDTA, pH 8.5]. A total of 20 µL of 2-mercaptoethanol (Sigma) was 
added to the mixture, followed by vortex-mixing and incubating 
FigUre 1 | isolation of Phoneutria nigriventer host defense effectors. (a) Semipreparative C18 reversed-phase high-performance liquid chromatography 
(RP-HPLC) of Sep-Pak C18 concentrated P. nigriventer non-infected eggs acidic extract. Highlighted fractions eluted between 20 and 55% acetonitrile. The fractions 
containing a peptide with 1.4 kDa and the oligoventin-enriched one were active against Micrococcus luteus A270. Fractions containing lysozymes are indicated with 
asterisks. These fractions were active against Candida albicans MDM8 and M. luteus A270, respectively. Absorbance was measured at 225 nm (A225). (B) MALDI 
spectra of native oligoventin. The inset shows the final purification of oligoventin. m/z, mass/charge ratio. (c) Multiple sequence alignment (MSA) showing 
evolutionary conservation of HECT domain C-terminal sequences from arachnids and oligoventin. Black and blue bars to the left of the alignment indicate oligoventin 
and Nedd4 proteins, respectively. (D) MSA showing evolutionary conservation of C-type lysozymes from vertebrates, insects, and arachnids. Shaded in black are 
highly conserved amino acid residues, whereas gray indicates moderately conserved residues. Connecting lines above sequences represent disulfide bridges. 
Structural coordinates were extracted from Gallus gallus C-type lysozyme (PDB entry 2LYZ). Cyan, blue, and navy blue bars to the left of the alignment indicate 
lysozymes from vertebrates, insects, and arachnids, respectively. Gray dotted lines represent tryptic peptides predicted by tandem MS.
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at 37°C for 2 h. After incubation, 100 µL of 4-vinylpyridine was 
added to the solution, followed by incubation at room temperature 
(26°C) for 2 h. The reduction and alkylation of the protein were 
confirmed by mass spectrometry. Reduced and alkylated proteins 
were digested with trypsin (Boehringer Mannheim) and tryptic 
peptides were analyzed by tandem mass spectrometry (MS/MS) 
in a Q-TOF Ultima API (Micromass) spectrometer operating in 
positive ion mode. In the mass spectrometer, doubly charged ions 
of sufficient abundance were selected for MS/MS fragmentation. 
MS/MS peak list files were submitted to an in-house version of 
MASCOT server (Matrix Science, USA) and screened against 
the Uniprot database. Representative resulting spectra and cor-
responding tables are provided in Table S1 in Supplementary 
Material.
arachnid genome screening
BLAST searches were done against the Ixodes scapularis IscaW1 
genome (42), a well-annotated arachnid genome resource, using 
oligoventin sequence as the query. Peptide–protein matching 
was adjusted with the following stringent settings: word size: 2; 
filter off; e-value 20,000; composition-based statistic off; PAM30 
scoring matrix.
hecT Domain homology Modeling and 
surface Mapping of conserved residues
The 3D model of the HECT domain was generated using the 
online server HHPred (43) for template identification and 
Modeller 9v15 (44) for the model construction. PDB entry 2ONI 
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was used as template (71% similarity). The quality of the final 
structure was accessed using MolProbity (45) showing just one 
residue out of the Ramachandran allowed region (Ala 61) and 
99.02% of the residues placed on the favorable region. Rate of 
amino acid evolution among Nedd4 HECT E3s was calculated 
from 50 homologs using maximum-likelihood phylogenetic 
analysis and mapped onto the protein structure using default 
parameters with Consurf (46).
computational simulations of 
Proteasomal Degradation
Human proteasome cleavage predictions were simulated 
with a stringent 0.7 threshold for four sequences (Table S3 in 
Supplementary Material) using the neural network algorithm 
Netchop3.1 online server “http://www.cbs.dtu.dk/services/
NetChop/.” We used the C-term 3.0 network, which is trained on 
1,260 naturally occurring MHC class I ligands (8, 47).
Phylogenetic reconstruction of 
eukaryotic nedd4 Diversification
Bayesian phylogenetic inference was carried out with modifica-
tions from Ref. (48). Orthologous sequences containing the 
HECT domain (PF00632) were collected from a large number 
of eukaryotes. A complete list of Uniprot identifiers was used for 
the acquisition of 4,392 HECT-containing protein sequences. 
Redundancy in our dataset was minimized by employing a 
clustering methodology using the CD-HIT software (49) with 
a threshold of >90%. One representative protein from each 
cluster was retrieved for further analysis. This yielded 318 
protein sequences relative to 370 eukaryotic species (Table S2 
in Supplementary Material), which were aligned with T-coffee 
(50). The final alignment was manually edited in GeneDoc 
(51) resulting in 2,470 sites. The choice of the best-fit model of 
evolution was performed with ProtTest3 (52) using the Akaike 
Information Criterion, which led us to choose the WAG model. 
The phylogenetic reconstruction was inferred by the Bayesian 
inference method implemented in the Beast v1.7.0 software 
(53, 54). The starting tree was randomly generated, and the pro-
portion of invariable sites and g-distributed rate variation across 
sites were estimated. The substitution rate categories were set in 
four categories, and we modeled the molecular clock accordingly 
to relaxed clock model available (55). The clades were supported 
by posterior probabilities obtained by Bayesian analysis. For 
Bayesian method generations, the burn-in was determined in 
Tracer (54) through log-likelihood scores, and data were sum-
marized in TreeAnnotator (54) after trees that were out of the 
convergence area had been discarded. A total of 10,000,000 trees 
were generated, from which 25,000 were burned out of the final 
tree. The visualization and the final tree edition were performed 
using FigTree v1.3.1 “http://tree.bio.ed.ac.uk/software/figtree/.” 
Finally, proteins belonging to each phylogenetic cluster were dis-
sected for revealing the oligoventin-orthologous sequence, from 
which sequence logos belonging to each clade were generated in 
Weblogo (56).
epitope comparison
The Immune Epitope Database (57) was screened using Nedd4 E3 
HECT proteins as queries and yielded nine MHC ligands.
resUlTs
identification of host Defense effectors
We combined solid-phase purification with assay-guided 
RP-HPLC runs to isolate host defense effectors from an acidic 
extract from P. nigriventer non-infected eggs. Four fractions 
with antimicrobial activity were found (Figure  1A). Mass 
analysis indicates that they were enriched for innate immune 
defense effectors, namely, HDPs and lysozymes (Figure S1 in 
Supplementary Material). To isolate these host defense effectors, 
analytical RP-HPLC runs coupled with bioassays yielded two 
fractions with molecules ranging in size from 0.8 to 1.7  kDa 
(Figures S1A–C in Supplementary Material), which were active 
against the Gram-positive bacteria M. luteus A270, and two 
lysozyme-like molecules ranging in size from 14 to 16  kDa 
(Figures S1D–F in Supplementary Material). A peptide with a 
mass of 1.4  kDa (Figure S1A in Supplementary Material) was 
purified to homogeneity, and Edman degradation showed that 
this peptide was N-terminally blocked. Further investigation by 
tandem mass spectrometry is needed to sequence this putative 
HDP. The fraction enriched for oligoventin (Figure  1A) was 
further purified. N-terminal sequencing by Edman degrada-
tion revealed an oligopeptide with eight residues: QPFSLERW, 
which we named oligoventin. Matrix-assisted laser desorption/
ionization—time of flight mass spectrometry (MALDI-ToF-MS) 
analysis of the resulting fraction shows that the oligoventin 
molecular weight (MW) observed 1,061.4 Da (M + H+ = 1,062.4, 
Figure 1B) corresponds to the MW calculated (1,061.5 Da).
Fractions enriched for lysozymes (Figures S1D–F in 
Supplementary Material) were active against the Gram-positive 
bacteria M. luteus A270 and the yeast C. albicans MDM8, 
respectively, and were further fractionated by C18 RP-HPLC. 
Reduction, alkylation, and trypsinization of these fractions 
followed by comparison of the resulting tryptic peptides by 
LC-ESI-MS/MS suggest that both of these antimicrobial factors 
are C-type lysozymes (Table S1 in Supplementary Material). 
Oligoventin and the putative HDP with 1.4  kDa show similar 
relative abundances. Altogether, these four antimicrobials rep-
resent less than 4% of the total protein content (Figure S2 in 
Supplementary Material).
Oligoventin antimicrobial activity and 
synergy with lysozymes
Oligoventin presents antimicrobial activity and MICs in the 
micromolar range (Table  1), markedly against Gram-positive 
bacteria: M. luteus A270 and the multi-resistant S. aureus ATCC 
29213 and S. epidermidis ATCC 12228 strains. It is also active 
against the yeast C. albicans MDM8 and the Gram-negative 
bacteria S. marcescens ATCC 4112. However, it has antimicro-
bial activity in concentrations higher than those of rondonin 
(35), a cryptic peptide derived from the oxygen-carrier protein 
hemocyanin (19, 35). Oligoventin is active at concentrations 
TaBle 1 | Minimal inhibitory concentrations (Mics) of hDPs from 
arachnids.
Microorganisms Mic (μM)
rondonin (35) Oligoventin
gram-positive bacteria
Micrococcus luteus A270 ND 47.2–94.5
Staphylococcus aureus ATCC 29213 ND 94.5–188.9
Staphylococcus epidermidis ATCC 12228 ND 94.5–188.9
gram-negative bacteria
Escherichia coli SBS363 NT ND
Escherichia coli ATCC 25922 NT ND
Pseudomonas aeruginosa ATCC 27853 NT ND
Serratia marcescens ATCC 4112 NT 23.53–47.2
Fungi
Trichosporon sp. IOC 4569 1.1–2.1 ND
Yeasts
Candida albicans MDM8 16.75–33.5 94.5–188.9
Candida krusei IOC 4559 16.75–33.5 ND
Candida glabrata IOC 4565 8.37–16.5 ND
Candida albicans IOC 4558 8.37–16.5 ND
Candida parapsilosis IOC 4564 16.75–33.5 ND
Candida tropicalis IOC 4560 8.37–16.5 ND
Candida guilliermondii IOC 4557 16.75–33.5 ND
The highest concentration tested was 189 µM. ND, activity was not detected in the 
range of concentrations tested. NT, antimicrobial activity was not tested or previously 
not reported (35). Rondonin is an hemocyanin-encrypted antifungal HDP from the 
tarantula Acanthoscurria rondoniae (19, 35).
MICs are expressed as the interval of two concentrations, where the first is the highest 
concentration tested at which microorganisms from each strain grew and the second is 
the lowest concentration tested that caused 100% growth inhibition (33–35, 38, 39).
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ranging from 47 to 188.9 µM, while rondonin is active from 16.5 
to 33.5 µM, except for the Tricosporon sp. IOC 4569 fungi strain, 
which is 2.1 µM (35). In contrast, oligoventin inhibits growth of 
Gram-positive, Gram-negative, and yeast strains, thus having a 
broader spectrum of antimicrobial activity compared to that of 
rondonin.
C-type lysozymes, classical players of innate immunity, are 
ubiquitous and constitutively expressed in leukocytes, providing 
an immediate defensive barrier to invading pathogens (20, 41, 58). 
Because context-specific co-expression of lysozymes with other 
host defense elements such as HDPs suggests synergy between 
these factors (41, 59), we investigated whether oligoventin has a 
mutually potentiating effect on the G. gallus C-lysozyme, as C-type 
lysozymes from arachnids are highly similar to avian lysozymes 
(Figure  1D). We determined the MIC of avian C-lysozyme as 
0.01–0.02 µM against M. luteus A270. When both factors were 
tested together against this strain, we found a 0.37 FIC index, 
indicating strong synergy (41) between these molecules (Table 
S2 in Supplementary Material). MIC of oligoventin is potentiated 
8-fold by lysozymes, exerting its effect at a concentration as low as 
11.81 µM, whereas oligoventin potentiates lysozymes by decreas-
ing its MIC 3.5-fold, causing growth inhibition at 0.006  µM. 
Moreover, oligoventin exhibits 4.3% hemolytic activity against 
human erythrocytes at 188.9  µM and 2% at 94.5  µM (Figure 
S3 in Supplementary Material). However, both oligoventin and 
lysozymes did not display antimicrobial activity against C. albi-
cans MDM8 when cultured in RPMI-1640 (Sigma-Aldrich) at pH 
5.0 or 7.0, even when oligoventin concentration was increased 
twofold relative to its MIC (376  µM). Similarly, although we 
determined lysozymes as having a MIC of 1.3–2.6  µM against 
C. albicans MDM8 in poor dextrose broth medium, this classical 
HDP also lacked antimicrobial activity in RPMI-1640, even when 
lysozyme concentration was increased more than 50-fold relative 
to its MIC (data not shown).
e3 Ubiquitin ligases as Oligoventin 
Precursor Proteins
To determine the oligoventin precursor protein, we BLAST 
screened the blacklegged tick I. scapularis genome IscaW1.4 from 
Vectorbase (42), a high-quality genomic resource for arachnids. 
Results showed high homology (88%) between oligoventin and 
the C-terminal HECT (Homologous to the E6-AP Carboxyl 
Terminus) domain sequence between residues 920–927 of Nedd4 
(neural precursor cell expressed, developmentally downregulated 
4-like) E3 ubiquitin ligases (Figure  1C; Figures S4 and S5 in 
Supplementary Material). Consistently, BLAST screening the 
Uniprot database with adjustments for peptide–protein match-
ing revealed similar results for orthologous Nedd4 from two 
arachnids (Ixodes ricinus, Uniprot ID: V5IJJ8, and Rhipicephalus 
pulchellus, Uniprot IDs: L7ML19, L7ME55) and one crustacean 
(Daphnia pulex, Uniprot ID: E9GKW9). These results suggest 
oligoventin is a cryptic peptide released by the proteolysis of a 
P. nigriventer Nedd4 protein ortholog. Alternative hypotheses 
of oligoventin precursor proteins are indicated in Table S3 in 
Supplementary Material.
3D molecular modeling of the blacklegged tick Nedd4 E3 
(Uniprot ID: B7Q5Q0) HECT domain (Figure  2A) shows the 
oligoventin-homologous epitope folding as a β-sheet and its 
close position to the catalytic cysteine site and the PY motif. PY 
motifs are internal regulatory motifs that are recognized by WW 
domains. Notice that the internal PY motif from HECT domains 
is different from the PPxY motifs found in substrates targeted 
also by the WW domains of catalytic HECT E3 ligases [reviewed 
in Ref. (60)] and herein we refer only to the regulatory PY motif 
from HECT domains.
Surface mapping projection of orthologous sequences 
onto the 3D model shows high-sequence conservation in the 
oligoventin-homologous, the catalytic site, and the regulatory PY 
motif C-terminal sequences (Figures 2B,C). Such high-sequence 
conservation suggests that the oligoventin-encrypted site is 
functionally important across different taxa.
In Silico Proteolytic Processing of e3 
Ubiquitin ligases by the 26s Proteasome
We used bioinformatics approaches to verify if oligoventin 
generation could occur by HECT E3s proteasome-mediated pro-
teolysis. A small dataset (Figure S5 in Supplementary Material) 
consisting of only the C-terminal Nedd4 HECT domain of 
ubiquitin ligase sequences for two invertebrates (the arachnid 
I. scapularis and the crustacean D. pulex) and two vertebrates 
(mouse and human) were used as input in NetChop3.1, a neural 
network algorithm trained to predict 26S proteasomal cleavage 
sites both for constitutive and immunoproteasomes (8, 47). This 
approach is appropriate because tissue-specific proteasomes, 
FigUre 2 | conservation of the oligoventin-encrypted site and in silico proteasomal degradation of e3s. (a) Homology modeling of the HECT domain 
from the arachnid B7Q8Q0 Nedd4 E3 ubiquitin ligase. Oligoventin is encrypted in a site between residues 920 and 927 (colored in red), which folds as a β-sheet. 
The catalytic site (Cys 274) and the PY motif (Pro281, Tyr 285) are colored in green and blue, respectively. (B,c) Surface mapping of conserved sites onto the 
arachnid Nedd4 HECT domain three-dimensional model. The arrow indicates the oligoventin-encrypted site. Teal represents the most variable residues and 
burgundy the most highly conserved. Model figures were generated using Pymol. (D) Proteasomal cleavage sites predicted for the HECT domain of four E3 
sequences from human, mouse, the blacklegged tick Ixodes scapularis, and the crustacean Daphnia pulex. The dashed line shows the 0.7 threshold.
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namely, constitutive, immune-, or thymus-specific proteasomes, 
are structurally rearranged in ways that combine different 
regulatory and catalytic domains, thus yielding different products 
(3–6, 8, 9, 47, 61). Therefore, simulating several proteasomes in a 
single prediction method magnifies the possibility of accurately 
mapping multiple cleavage sites onto a template protein (8, 47). 
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Figure  2D shows the site positioned within the amino acid 
residues 920–927 in which oligoventin shows marked homol-
ogy (Figure  1C) is enriched for cleavage sites in all sequences 
evaluated. In contrast, the flanking residues lack cleavage sites 
(Figure S6 and Table S4 in Supplementary Material). These results 
suggest high conservation of cleavage sites within metazoan E3s. 
Therefore, our approach indicates that Nedd4 26S proteasome-
mediated proteolysis might explain oligoventin production from 
an E3 ubiquitin ligase precursor protein.
Phylogenetic analysis reveals an ancient 
hDP signature in Metazoan nedd4s
In spite of the HECT domain deep conservation (Figures 2B,C), 
HECT E3s are pervasive within eukaryotic genomes, compris-
ing more than 33 protein families highly diversified in animals, 
which have undergone wide architectural rearrangement (1–7). 
Therefore, our structural conservation data do not inform to 
what extent the different HECT-containing E3 families may 
contribute to oligoventin production. To address this issue, we 
conducted a comprehensive Bayesian phylogenetic analysis on 
318 orthologous sequences recovered from all major eukaryotic 
clades (Table S5 in Supplementary Material), which yielded a 
tree topology (Figure 3A) consistent with previous findings (2). 
Our results indicate that Nedd4 proteins are enriched for the 
oligoventin motif, but not WWP, Itchy, Smurf, and fungal Nedd4 
HECT ligases. Figure 3B illustrates sequence logos for each corre-
sponding encrypted site within sampled orthologous sequences. 
We found that Nedd4s are enriched for a motif composed of 
Q(P/M/L)F(S/T)(L/I)E(R/K/Q)W. In arthropods positioned near 
the base of extant ecdysozoans, namely, crustaceans and arach-
nids, the motif is more pronounced, with two conservative amino 
acid substitutions, one at the fourth position (S/T) and another 
at the seventh (K/R). The oligoventin sequence signature is also 
encrypted to some extent in Nedd4 from insects and vertebrates, 
with a single non-conservative change at the seventh position in 
chordates.
Possible convergent evolution of the UPP 
in Metazoan immune systems
Because all nucleated cells from jawed vertebrates present their 
own antigens derived from cytosolic proteins to cytotoxic T cells 
through MHC class I (3, 4, 8, 9, 16, 47, 57), we investigated if 
human and mouse Nedd4 proteins (7, 60) were involved in anti-
gen presentation as a means of comparing the contribution of 
HECT E3s to the adaptive and innate immune systems. Screening 
the Immune Epitope Database (57) for Nedd4-derived antigens 
yielded nine peptides, ranging in size from 8 to 16 residues (MWs 
between 0.9 and 1.2 kDa), indeed involved in antigen presenta-
tion as revealed by MHC ligand assays (Table 2). These results 
strongly support the hypothesis of convergent evolution of the 
UPP function in immunity. Therefore, it seems that the UPP was 
co-opted multiple times in immune systems. Whereas in mam-
mals, Nedd4 E3s play a role in the adaptive immune system as 
a core member of the UPP (2, 7, 9, 16, 47, 57, 60, 62) and as 
precursors for MHC class I antigens in mammals (e.g., Table 2), 
it is possible that a function for E3s has also evolved in the innate 
defense as precursors of HDPs in a pathway likely dependent on 
the ubiquitin–proteasome system, at least in arachnids (Figure 4).
DiscUssiOn
Our analysis suggests that a novel player in the ancient yet diverse 
innate immune system from arachnids (17, 19–21, 34, 35), olig-
oventin, shares homology to the catalytic HECT domain of meta-
zoan Nedd4 E3 ubiquitin ligases. Computational dissection of 
hundreds of HECT E3 ubiquitin ligases indicates that production 
of oligoventin-like HDPs might be limited to Nedd4 orthologs, 
as the oligoventin signature is encrypted in metazoan Nedd4s, 
but not in Nedd4s from fungi nor in the closely related metazoan 
WWP/Itch, Smurf and HECW HECT-containing E3s, which 
might represent paralogs of this family of ligases. However, it is 
also possible that other classes of E3s can be involved in releasing 
additional HDPs. In fact, the results summarized in Table 2 show 
that other HECT-containing E3s also produce functional peptides, 
such as HECW1 and HECW2; therefore, it is likely that other 
E3s can mediate the production of functional peptides, consistent 
with the low numbers of HECT-containing ligases in arachnid 
genomes (63). Indeed, while Nedd4 or Nedd4-2-deficient mice 
show a variety of phenotypes including embryonic and neonatal 
lethality (60), recent studies provided evidence that other classes 
of E3s (RING-containing) play a role in arachnid host defense, at 
least against the bacterial pathogen Anaplasma phagocytophilum 
(64–66), as suggested by silencing the E3 ligase XIAP in I. scapu-
laris ticks (64). However, the underlying mechanism of the role of 
E3 in tick host defense remains elusive (64–66), and it would be 
interesting to test whether XIAPs are precursors of HDPs or are 
involved in the regulation of innate immune pathways.
The proposed homology between an antimicrobial peptide 
and the catalytic HECT domain of an E3 ubiquitin ligase imme-
diately suggests a mechanism of oligoventin production by E3s 
self-proteolysis. E3 ubiquitin ligases are involved in the last step of 
ubiquitination, flagging substrates with ubiquitin for proteasomal 
degradation (1–8). Thus, E3s are the components that confer 
specificity to the UPP (3–6). E3s containing the HECT domain 
first form an intermediate thioester bond between the catalytic 
cysteine and ubiquitin before transferring this moiety to a lysine 
residue in the target substrate (4–6). In fact, the intermediate 
thioesther formation with ubiquitin is critical to HECT E3s in 
cis self-ubiquitination activity (5, 6). Hence, a parsimonious 
mechanism of generating the HDP oligoventin would be HECT 
E3s self-ubiquitination coupled with proteasomal degradation. 
Indeed, our in silico simulation of the proteolysis of E3 ligases is 
consistent with the idea that oligoventin is generated as a product 
of the proteasomal degradation of E3s. It might be, therefore, 
straightforward to recruit the UPP to generate diverse HDPs from 
targeted cytosolic proteins, as it is for production of MHC class I 
antigens (3, 4, 8, 9, 16, 62).
Nevertheless, we cannot rule out the possibility that oligoven-
tin can be generated by non-self-ubiquitination of oligoventin 
precursors coupled with proteasomal degradation [that is, E3s in 
trans ubiquitination (5, 6)], or ubiquitin- or proteasomal-inde-
pendent proteolysis [e.g., by selective macroautophagy (26–29)]. 
In fact, Nedd4 proteins preferentially conjugate the K63 linkage 
FigUre 3 | Oligoventin signature conserved within metazoans suggests nedd4 e3 ubiquitin ligases as the precursor protein candidate of 
oligoventin. (a) Bayesian phylogenetic inference of 318 HECT-containing E3s. (B) Oligoventin-orthologous sequence signatures for major protein subfamilies 
comprised of Nedd4, WWP-Itchy, Smurf, and fungal Nedd4 HECT E3 ligases groups. Silhouettes from organisms are from Phylopic (http://phylopic.org/).
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TaBle 2 | endogenous antigens derived from e3 ligases from the nedd4 family involved in Mhc-mediated antigens presentation.
epitope iD Peptide MW antigen name species Method Mhc allele 
name
Mhc 
class
191812 SGLCNEDHL 986.4 E3 ubiquitin-protein ligase 4-like isoform 1 Mus musculus Cellular MHC/mass 
spectrometry
H2-Db I
214505 LPFEKSQL 960.5 NEDD4-like E3 ubiquitin-protein ligase WWP2 
isoform 3
Homo sapiens Cellular MHC/mass 
spectrometry
HLA-B*08:01 I
225136 YFDEKELEL 1,184.5 NEDD4-like E3 ubiquitin-protein ligase WWP2 H. sapiens Cellular MHC/mass 
spectrometry
HLA-C*04:01 I
241145 ARAPAPYKR 1,184.5 E3 ubiquitin-protein ligase HECW2 H. sapiens Mass spectrometry HLA-B*27:05 I
241758 GGSARTATAASEQSPG 1,028.5 NEDD4-like E3 ubiquitin-protein ligase WWP2 M. musculus Mass spectrometry HLA-DQ8 II
422506 KSRPIIKRF 1,446.6 E3 ubiquitin-protein ligase HECW1 H. sapiens Cellular MHC/mass 
spectrometry
HLA-B*57:01 I
422718 SGLCNEDHL + OX(C4) 1,143.7 E3 ubiquitin-protein ligase NEDD4-like isoform 1 M. musculus Cellular MHC/mass 
spectrometry
H2-class I I
424855 GFLRLKMAY 986.4 E3 ubiquitin-protein ligase NEDD4-like isoform 6 H. sapiens Cellular MHC/mass 
spectrometry
HLA-A*29:02 I
429266 ASDPYVKLSLY 1,097.5 E3 ubiquitin-protein ligase NEDD4-like H. sapiens Cellular MHC/mass 
spectrometry
HLA-A*01:01 I
MW, molecular weight.
Antigens were retrieved from the Immune Epitope Database (57).
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ubiquitin chain on substrate proteins, which alters the signal-
ing properties or trafficking pattern of these modified proteins, 
instead of the K48 linkage ubiquitin chain that usually directs 
ubiquitinated proteins to proteasomal degradation (64, 67). 
Therefore, it is more likely that oligoventin precursors are ubiquit-
inated by other E3s conjugating K48 linkages. Furthermore, it can 
be argued that alternative mechanisms can explain production of 
short HDPs such as oligoventin. For example, long non-coding 
RNAs that produce short-sized biologically active peptides (68, 
69) or proteasomal-independent production of encrypted HDPs 
(26–28) might underlie the generation of oligoventin. However, 
the biochemical, phylogenetic, and computational evidence pre-
sented here supports a model in which E3s release oligoventin by 
proteasomal proteolysis.
Oligoventin production by proteasomal degradation suggests 
that this peptide can be stored in intracellular compartments, 
similar to MHC class I antigens (8, 9, 47, 70) and then be directed 
to the extracellular space where it might play its functional role. 
Indeed, previous studies suggest that spider hemocytes (immune 
cells similar to mammalian macrophages) preferentially export 
antimicrobial effectors, such as acanthoscurrins and gomesins 
(33, 34), through exocytosis (71), contrasting with vertebrate 
macrophages, which preferentially display phagocytic activity 
against pathogens (71, 72). Therefore, the model in which oli-
goventin is derived from E3s proteasomal-mediated proteolysis 
could provide an extraordinary example of convergent evolution 
in which highly conserved orthologous pathways (e.g., TAP-
dependent) direct proteasomal products to their extracellular 
site, despite functional divergence of those products. However, 
as some ubiquitin-encrypted HDPs are produced in autophago-
somes (26–28), it is also possible that oligoventin can be produced 
by proteasomal-independent selective degradation of cytosolic 
Nedd4 proteins during macroautophagy of invading pathogens.
Together with the discovery of oligoventin, the presence of two 
lysozymes and a putative HDP of 1.4 kDa reveals hallmarks of an 
ancient immune defense system (17–21). Although oligoventin 
alone shows a relatively weak antimicrobial activity (Table 1), it 
has potent synergy with lysozymes, thus providing evidence of 
putative E3-derived peptides playing an important role in modu-
lating the innate defenses of P. nigriventer. Moreover, because 
some arachnids lack inducible production of HDPs (17, 19–21, 34, 
71), it is possible that oligoventin is constitutively expressed dur-
ing early development, as it was discovered in non-infected eggs. 
Alternatively, antimicrobial factors such as HDPs, lysozymes, 
and antibodies are either maternally deposited or upregulated 
by parental imprinting within several taxa, including, but not 
limited to, cnidarians (73), insects (74, 75), amphibians (76), and 
amniotes (77), such as birds, rats, and humans, then it is possible 
that oligoventin has a maternal origin and could play a role in 
regulating early microbial colonization during development.
Future research can benefit from MALDI imaging mass spec-
trometry (78, 79) to investigate E3-mediated production of HDPs 
in vivo. Combining MALDI imaging with the recently developed 
ubiquitin variants (80), which systematically modulate HECT E3 
ligase activity, as well as proteasome inhibitors (81), will be useful 
to probe the mechanism of HDP production proposed herein. 
Furthermore, the i5k initiative (82) aims to sequence 63 arachnid 
genomes, including P. nigriventer itself and two closely related 
species from the Ctenidae family: Phoneutria fera and Cupiennius 
salei (83). Therefore, we expect that the community-based efforts 
to annotate their genomes will provide the sequence data needed 
to test if oligoventin indeed maps to ctenid HECT E3 ligases.
Oligoventin synergy with C-type lysozymes suggests this HDP 
is a lysozyme-partner effector. When combined with lysozymes, 
oligoventin inhibits clinically isolated Gram-positive bacteria 
growth in vitro at concentrations as low as 11.8 µM. Thus, further 
research should test whether oligoventin is expressed in other tis-
sues in addition to the eggs, which would indicate that it engages 
in constitutive innate immunity together with lysozymes at dif-
ferent developmental stages. Furthermore, the fact that synergy 
between antimicrobials might reduce the cost of defense (41, 59, 
84) indicates that arachnids might be able to defend themselves 
FigUre 4 | self-proteolysis of ubiquitin e3 ligases as a mechanism 
mediating production of functionally diverse peptides in metazoan 
host defense. Our results suggest that putative ubiquitinated E3s undergo 
proteasome-mediated proteolysis, yielding E3-derived HDPs. In arachnids, 
the HDP oligoventin is predicted to be produced from the degradation of an 
Nedd4 E3 and may act as a host defense effector in combination with 
lysozymes. In jawed vertebrates, the proteasomal degradation of E3s 
produces antigens, which are then transported by ATP-binding cassette 
proteins (TAPs) and assembled in the endoplasmic reticulum (ER) with  
MHC class I receptors for presentation in antigen-presenting cells (APCs). 
Therefore, E3s degradation mediated by the ubiquitin–proteasome system 
might have been independently repurposed multiple times during metazoan 
evolution to play roles in the immune system as functionally diverse as 
endogenous antigens and host defense effectors.
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against a wide range of pathogens from a relatively limited rep-
ertoire of host defense effectors. Synergy between two distinct 
classes of antimicrobials is usually explained by different modes 
of action between the effector molecules (41, 59, 84). Hence, 
lysozyme-induced bacterial peptideglycan disruption (41, 58) 
might facilitate oligoventin binding to its target, possibly explain-
ing their synergy. Because oligoventin is a neutrally charged 
antimicrobial peptide, varying its net charge from −1 to 0.8 in 
pHs 10.0 and 4.0, respectively, we suggest that it is unlikely that 
it binds directly to anionic membranes, although it could bind 
to membrane receptors. However, neutrally charged peptides 
usually act by binding to intracellular targets such as catalytic 
enzymes and nucleic acids, in contrast to cationic antimicrobial 
peptides directly disrupting membranes (40, 85, 86). Therefore, 
future studies aiming to understand oligoventin’s mode of action 
might reveal the underlying mechanism of synergy of oligoventin 
with lysozymes.
Despite oligoventin’s small size, antimicrobial activity against 
clinical strains, synergy with lysozymes, and lack of hemolytic 
activity, its discovery will likely be of limited interest to drug devel-
opment as many short-sized peptides such as gomesin (34) and 
rondonin (35), among others (84–89), outcompete oligoventin’s 
attractiveness as a blueprint for next-generation antimicrobial 
drugs. However, the discovery of oligoventin highlights the 
potential to screen E3s for novel peptide-based drug discovery 
(90). At present, the identification of oligoventin provides two 
main insights: first, the discovery of E3-derived peptides as a 
possibly new class of biologically active peptides. Second, it sheds 
new light on comparative immunology by illustrating a remark-
able case of independent evolution of UPP function in animal 
host defense. Therefore, the most relevant result of our study is 
the evidence suggesting that E3 degradation might have been 
independently repurposed leading to the production of MHC 
class I antigens at least in humans and mouse and possibly HDPs 
in arachnids, respectively. Our findings indicate that the UPP was 
independently coupled to different immune pathways during the 
evolution of metazoans as a possibly convergent adaptation of 
metazoan immunity to produce functionally diverse peptides.
In conclusion, our data support the prediction that Nedd4s 
play a role in a new innate immune-related cellular pathway 
dependent on the UPP. The evidence presented suggests an 
emergent function of HECT E3s as novel precursors of HDPs 
in the ancient arachnid innate immune system. If confirmed, it 
will highlight the functional plasticity of the UPP and expand 
the currently known function of E3s (3, 4, 6, 7, 60, 62, 91). Thus, 
our results are consistent with the hypothesis that the UPP has 
been independently co-opted several times during evolution and 
gained multiple immune-related functions. Further experimen-
tation is therefore necessary to robustly test the postulated role of 
Nedd4 proteins in immunity suggested by the data presented here 
and also to further test the precise molecular origin of oligoventin.
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